Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2005-11-21
2008-08-12
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C435S326000, C530S388100, C424S141100
Reexamination Certificate
active
07410641
ABSTRACT:
The present invention relates to antibodies that bind to the A chain N-terminal peptide. The present invention also relates to (1) a polypeptide containing the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO:7 (A chain), (2) a polypeptide containing the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO:8 (B chain), (3) a polypeptide wherein the A and B chains are bonded to each other via disulfide bonds (2 chains) or its salt., (4) DNAs encoding the same, etc. These polypeptides and DNAs encoding the same can be used for the diagnosis, treatment, prevention, etc. for diseases, including abnormalities (e.g., diabetes mellitus, etc.) in metabolic regulation (sugar metabolism, lipid metabolism, etc.) of energy sources such as carbohydrates.
REFERENCES:
patent: 2002/0012967 (2002-01-01), Holloway et al.
patent: WO 99/15664 (1999-04-01), None
patent: WO 00/21996 (2000-04-01), None
patent: WO 00/32221 (2000-06-01), None
patent: WO 00/47776 (2000-08-01), None
patent: WO 01/68862 (2001-09-01), None
patent: WO 02/22802 (2002-03-01), None
Bullesbach et al., SEQ ID No. 7 sequence alignment result.
Bullesbach et al., SEQ ID No. 8 sequence alignment result.
Bullesbach, E., et al., “The Relaxin-Like Factor is a Hormone”,Endocrine, (1999), vol. 10, No. 2, pp. 167-169.
Bani, D., “Relaxin: A Pleiotropic Hormone”,Gen. Pharmac. (1997), vol. 28, No. 1, pp. 13-22.
Berger, S., et al., “Statistical Approach for Evolutionary Relationship of a-Conotoxins and Members of Insulin-Superfamily”,Horm. Metab. Res., (1996), vol. 28, pp. 535-540.
James, R. et al., “Primary Structure of Porcine Relaxin: Homolgy with Insulin and Related Growth Factors”,Nature, (1977), vol. 267, pp. 544-546.
Haley, J., et al., “Porcine Relaxin”,The Journal of Biological Chemistry, (1987), vol. 262, No. 25, pp. 11940-11946.
Gowan, L., et al., “On the Primary and Tertiary Structure of Relaxin from the Sand Tiger Shark (Odontaspis taurus)”,FEBS Letters, (1981), vol. 129, No. 1, pp. 80-82.
Bullesbach, E., et al., Isolation, Purification, and the Sequence of Relaxin from Spiny Dogfish (Squalus acanthias),Eur. J. Biochem., (1986), vol. 161, pp. 335-341.
XP-002282992, Jan. 27, 2000, EMBL:AC022098.
Harada Masataka
Itoh Yasuaki
Kizawa Hideki
Nishi Kazunori
Ogi Kazuhiro
Finnegan Henderson Farabow Garrett & Dunner LLP
Saoud Christine J
Takeda Pharmaceutical Company Limited
LandOfFree
Antibodies to insulin/IGF/relaxin family polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to insulin/IGF/relaxin family polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to insulin/IGF/relaxin family polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3997212